Home › Funds › Parkman Healthcare Partners LLC › AVTX

Parkman Healthcare Partners LLC position in AVTX

AVALO THERAPEUTICS INC · Health Care

Parkman Healthcare Partners LLC reported holding 929,432 shares of AVTX (AVALO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.2M, representing 1.29% of its reported portfolio and ranking #28 among its reported holdings. Parkman Healthcare Partners LLC has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)929.43K sh
Reported value held$14.25M
Portfolio Weight1.29%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's AVTX position evolved

Parkman Healthcare Partners LLC first disclosed a stake in AVTX in Q2 2026 at 766,290 shares (US$14.2M). The position peaked in Q3 2026 at 929,432 shares, worth US$14.2M. Across 2 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 929,432 shares valued at US$14.2M — an increase of 163,142 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 766.29K $14.16M New
Q3 2026 929.43K $14.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVTX and 13F data

AVTX (AVALO THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in AVTX — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$60.9M), Caligan Partners LP (US$58.5M), Deep Track Capital, LP (US$55.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVTX

All AVTX fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held AVTX?

Parkman Healthcare Partners LLC has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Parkman Healthcare Partners LLC's current position in AVTX?

As of Q3 2026, Parkman Healthcare Partners LLC holds 929.43K shares of AVTX (AVALO THERAPEUTICS INC), valued at $14.25M, representing 1.29% of its reported portfolio and ranking #28.

Has Parkman Healthcare Partners LLC been buying or selling AVTX?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in AVTX. The position peaked in Q3 2026 at 929.43K shares.

Which other funds hold AVTX?

Other major institutional holders of AVTX include FARALLON CAPITAL MANAGEMENT, L.L.C., Caligan Partners LP, Deep Track Capital, LP, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.